Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TALQUETAMAB-TGVS: 828 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
828
Total FAERS Reports
63 (7.6%)
Deaths Reported
141
Hospitalizations
828
As Primary/Secondary Suspect
23
Life-Threatening
4
Disabilities
Prescription
Status

FDA Application: 761342 ·

First Report: 20211001 · Latest Report: 20250916

What Are the Most Common TALQUETAMAB-TGVS Side Effects?

#1 Most Reported
Cytokine release syndrome
162 reports (19.6%)
#2 Most Reported
Ageusia
88 reports (10.6%)
#3 Most Reported
Weight decreased
74 reports (8.9%)

All TALQUETAMAB-TGVS Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Cytokine release syndrome 162 19.6% 19 36
Ageusia 88 10.6% 0 15
Weight decreased 74 8.9% 3 12
Dysgeusia 73 8.8% 5 7
Skin exfoliation 65 7.9% 2 12
Immune effector cell-associated neurotoxicity syndrome 55 6.6% 10 21
Dry mouth 53 6.4% 1 9
Off label use 51 6.2% 2 10
Rash 48 5.8% 3 6
Onychomadesis 46 5.6% 0 4
Nail disorder 45 5.4% 2 3
Taste disorder 40 4.8% 2 7
Pyrexia 39 4.7% 0 11
Death 34 4.1% 34 6
Dry skin 33 4.0% 2 9
Fatigue 33 4.0% 1 9
Decreased appetite 30 3.6% 2 8
Dysphagia 29 3.5% 2 6
Plasma cell myeloma 29 3.5% 8 8
Infection 23 2.8% 6 7

Who Reports TALQUETAMAB-TGVS Side Effects? Age & Gender Data

Gender: 44.5% female, 55.5% male. Average age: 65.0 years. Most reports from: US. View detailed demographics →

Is TALQUETAMAB-TGVS Getting Safer? Reports by Year

YearReportsDeathsHosp.
2021 1 0 0
2022 3 0 0
2023 42 3 15
2024 93 7 34
2025 92 4 23

View full timeline →

What Is TALQUETAMAB-TGVS Used For?

IndicationReports
Product used for unknown indication 422
Plasma cell myeloma 326
Plasma cell myeloma refractory 64
Plasma cell leukaemia 5

TALQUETAMAB-TGVS vs Alternatives: Which Is Safer?

TALQUETAMAB-TGVS vs TAMIFLU TALQUETAMAB-TGVS vs TAMOXIFEN TALQUETAMAB-TGVS vs TAMSULOSIN TALQUETAMAB-TGVS vs TAPENTADOL TALQUETAMAB-TGVS vs TAPINAROF TALQUETAMAB-TGVS vs TARCEVA TALQUETAMAB-TGVS vs TARLATAMAB TALQUETAMAB-TGVS vs TARLATAMAB-DLLE TALQUETAMAB-TGVS vs TASIGNA TALQUETAMAB-TGVS vs TASIMELTEON

Official FDA Label for TALQUETAMAB-TGVS

Official prescribing information from the FDA-approved drug label.